RARS2

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RARS2 mutation is significantly associated with the RNA expression of many other genes, with 2,239 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible RARS2-associated genes across cancer lineages are RNA5SP34, LINC00326, and FEM1AP1. Each is linked with RARS2 in more than 2 cancer types. Because this analysis shows association rather than direction, both RARS2-to-partner and partner-to-RARS2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNA5SP34 grouped by RARS2-low versus RARS2-high in BRCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (RARS2→partner) and Y-score (partner→RARS2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCARNA5SP34 →+0.175+7.471.009.00833
READLINC00326 →+0.826+5.421<.001.00532
UCECFEM1AP1 →+0.020+2.368<.001.00432
UCECMTRF1LP1 →+0.100+1.635.003.00832
BRCAMIR3675 →+0.278+7.471<.001.00832
COADIGKV1OR9-1 →+0.749+4.624<.001.00132
Each partner links to its Q-omics profile. Showing the 6 strongest of 2,239 associations by consensus.

RNA5SP34 by RARS2 expression — BRCA

Box plot of RNA5SP34 in RARS2-low vs RARS2-high samples in BRCA.

Explore this box plot interactively →

Exploration